Emerging Infectious Disease ISSN: 1080-6059

Lymphogranuloma Venereum in Men Screened for Pharyngeal and Rectal Infection, Germany

Karin Haar

, Sandra Dudareva-Vizule, Hilmar Wisplinghoff, Fabian Wisplinghoff, Andrea Sailer, Klaus Jansen, Birgit Henrich, and Ulrich Marcus

Author affiliations: Author affiliations: Robert Koch-Institute, Berlin, Germany (K. Haar, S. Dudareva-Vizule, A. Sailer, K. Jansen, U. Marcus); European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden (S. Dudareva-Vizule); University of Cologne, Cologne, Germany (H. Wisplinghoff); Laboratoriumsmedizin Köln–Dres. med. Wisplinghoff and Colleagues, Cologne (H. Wisplinghoff, F. Wisplinghoff); Heinrich-Heine-University, Duesseldorf, Germany (B. Henrich)

Main Article

Figure

Flowchart of testing of 1,883 men who have sex with men for Chlamydia trachomatis (CT) and lymphogranuloma venereum (LGV) by RNA- and DNA-based assays, Germany, December 1, 2009–December 31, 2010. Gray shading indicates samples positive for CT that were sent for L genotyping. Most participants provided >1 type of sample.

Figure. . . . Flowchart of testing of 1,883 men who have sex with men for Chlamydia trachomatis (CT) and lymphogranuloma venereum (LGV) by RNA- and DNA-based assays, Germany, December 1, 2009–December 31, 2010. Gray shading indicates samples positive for CT that were sent for L genotyping. Most participants provided >1 type of sample.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.